SCHEMBL6283755

SCHEMBL6283755

COc1ccc(-c2csc3cccc(OC)c23)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.51
ALDH1A1 P00352 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
GPR55 Q9Y2T6 1/20 0.51
LMNA P02545 3/20 0.48
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.46
TP53 P04637 2/20 0.45
FGFR1 P11362 2/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.45
POLB P06746 1/20 0.44
SIRT5 Q9NXA8 1/20 0.44
ABL1 P00519 1/20 0.44
ABCB1 P08183 1/20 0.44
BCR P11274 1/20 0.44
EPHB4 P54760 1/20 0.43
MAOB P27338 1/20 0.43
SYK P43405 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6283572 0.86 HSP90AA1 (0.49) MAPTALDH1A1SMN1; SMN2GPR55LMNA
SCHEMBL6286685 0.83 MAPT (0.45) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL5368387 0.79 MAOB (0.54) MAPTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL7501599 0.78 MAOB (0.53) MAPTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL1704521 0.74 ABL1 (0.62) MAPTALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL5273487 0.73 PRF1 (0.42) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL5542674 0.71 CA2 (0.38) MAPTALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL22072873 0.69 ABL1 (0.52) MAPTALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL27755757 0.69 SYK (0.56) MAPTALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL12715050 0.69 ABL1 (0.79) MAPTSMN1; SMN2LMNATP53ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6921827-B2 Process for preparing 3-aryl-benzo{b} thiophenes ELI LILLY AND COMPANY (US) 2005-07-26 US disclosed
US-20040132775-A1 Process for preparing 3-aryl-benzo{b} thiophenes LUKE WAYNE DOUGLAS (US) 2004-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040132775-A1 Process for preparing 3-aryl-benzo{b} thiophenes TBCB, CYP1B1, TST MAPT 2868/4885ALDH1A1 2025/4885SMN1; SMN2 3846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.